The Journal of Pathology
The Journal of Pathology
5 years ago

HMGB1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells

Xiu-Wu Bian, De-Yu Guo, Lu Lu, Jiao Tan, Xia Zhang, Wen-Juan Fu, Xi-Long Zhao, Ji Ming Wang, Yi-Fang Ping, Ze-Xuan Yan, Xu-Gang Hu, Jun Jiang, Yong Lin, Xiao-Hong Yao, Hsiang-Fu Kung, Yan Liang, Xue Liu, Qin Niu, Shuai Yang, Zhuo Tang
Cancer stem/initiating cells (CSCs/CICs) and their microenvironmental niche play a vital role in malignant tumour recurrence and metastasis. Cancer associated fibroblasts (CAFs) are major components of the niche of breast cancer initiating cells (BCICs) and their interactions may profoundly affect breast cancer progression. Autophagy has been considered as a critical process for CIC maintenance, but whether it is involved in the cross-talk between CAFs and CICs to affect tumourigenesis and pathological significance remains elusive. In this study, we found that the presence of CAFs containing high levels of LC3II, a maker of autophagosomes, was associated with more aggressive luminal human breast cancer. CAFs in human luminal breast cancer tissues with high autophagy activity enriched BCICs with increased tumourigenicity. Mechanistically, autophagic CAFs released high-mobility group box 1 (HMGB1) that activated its receptor TLR4 expressed by luminal breast cancer cells to enhance their stemness and tumourigenicity. Furthermore, immunohistochemistry of 180 luminal breast cancers revealed that high LC3II/TLR4 levels predicted an increased relapse rate and poorer prognosis. Our findings demonstrate that autophagic CAFs play a critical role in promoting the progression of luminal breast cancer through a HMGB1/TLR4 axis, and both autophagy in CAFs and TLR4 on breast cancer cells constitute potential therapeutic targets.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/path.4958

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.